BioCentury
ARTICLE | Company News

NIH, KannaLife Sciences deal

September 1, 2014 7:00 AM UTC

KannaLife said NIH granted the company a license to develop and commercialize U.S. Patent No. 6,630,507, which covers cannabinoid- and cannabidiol-based therapeutics as antioxidants and neuroprotectan...